We are investors in life sciences managing two funds.
is a mutual fund which started in 2016 and invests in the most promising public life sciences companies. The fund mainly invests in small and mid cap biotech companies in the EU and US. See further under Aescap2.0.
is a venture capital fund which started investing in private life sciences companies late 2006 from a 100 million euro fund. The fund so far made several good exits and has still several companies under management which will be slowly divested. See further under Aescap I.